Recently, Endovastec™ announced the first commercial implantation of its Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™) in Kazakhstan. This marks the latest addition to the company’s product portfolio in this region, following of its Castor™ Branched Aortic Stent Graft System.

The procedure was performed by Dr. Aripov Marat and his team at the Department of Cardiothoracic Surgery and Radiology at the Corporate Fund University Medical Center Hospital.

The patient, a 63-year-old male, was diagnosed with an abdominal aortic aneurysm, complicated by severe calcification at the iliac artery access site. Based on preoperative imaging and measurements, Dr. Marat and his team selected the Minos™ system as part of a tailored treatment plan.

Postoperative imaging confirmed smooth stent deployment, with the stent maintaining its intended configuration and sealing, contributing to a successful outcome.

Minos™ is Endovastec™’s flagship product in abdominal aortic intervention. It is designed for the endovascular treatment of abdominal aortic aneurysms with a proximal neck length of ≥15mm. It is the first China developed product to reduce the outer sheath diameter of the delivery system to 14F, significantly lowering the requirements for vascular access during surgery. Featuring a three-piece structure design, it can be flexibly assembled inside the body, maximizing coverage of the diseased area. It offers unique advantages in treating complex abdominal aortic aneurysms, especially in cases involving tortuous necks, short necks, or narrowed entry arteries.

Minos™ is currently in clinical use in over 1,000 hospitals across more than 20 countries, with growing adoption supported by physician feedback and ongoing clinical experience.